Cite
Pradhan R, Singh S. Comparison of Data on Serious Adverse Events and Mortality in ClinicalTrials.gov, Corresponding Journal Articles, and FDA Medical Reviews: Cross-Sectional Analysis. Drug Saf. 2018;41(9):849-857doi: 10.1007/s40264-018-0666-y.
Pradhan, R., & Singh, S. (2018). Comparison of Data on Serious Adverse Events and Mortality in ClinicalTrials.gov, Corresponding Journal Articles, and FDA Medical Reviews: Cross-Sectional Analysis. Drug safety, 41(9), 849-857. https://doi.org/10.1007/s40264-018-0666-y
Pradhan, Richeek, and Singh, Sonal. "Comparison of Data on Serious Adverse Events and Mortality in ClinicalTrials.gov, Corresponding Journal Articles, and FDA Medical Reviews: Cross-Sectional Analysis." Drug safety vol. 41,9 (2018): 849-857. doi: https://doi.org/10.1007/s40264-018-0666-y
Pradhan R, Singh S. Comparison of Data on Serious Adverse Events and Mortality in ClinicalTrials.gov, Corresponding Journal Articles, and FDA Medical Reviews: Cross-Sectional Analysis. Drug Saf. 2018 Sep;41(9):849-857. doi: 10.1007/s40264-018-0666-y. PMID: 29644579.
Copy
Download .nbib